The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
MicroRNA-29c Is a Signature MicroRNA under High Glucose Conditions That Targets Sprouty Homolog 1, and Its in Vivo Knockdown Prevents Progression of Diabetic Nephropathy
Open accessAbstract
Although several recent publications have suggested that microRNAs contribute to the pathogenesis of diabetic nephropathy, the role of miRNAs in vivo still remains poorly understood. Using an integrated in vitro and in vivo comparative miRNA expression array, we identified miR-29c as a signature miRNA in the diabetic environment. We validated our profiling array data by examining miR-29c expression in the kidney glomeruli obtained from db/db mice in vivo and in kidney microvascular endothelial cells and podocytes treated with high glucose in vitro. Functionally, we found that miR-29c induces cell apoptosis and increases extracellular matrix protein accumulation. Indeed, forced expression of miR-29c strongly induced podocyte apoptosis. Conversely, knockdown of miR-29c prevented high glucose-induced cell apoptosis. We also identified Sprouty homolog 1 (Spry1) as a direct target of miR-29c with a nearly perfect complementarity between miR-29c and the 3'-untranslated region (UTR) of mouse Spry1. Expression of miR-29c decreased the luciferase activity of Spry1 when co-transfected with the mouse Spry1 3'-UTR reporter construct. Overexpression of miR-29c decreased the levels of Spry1 protein and promoted activation of Rho kinase. Importantly, knockdown of miR-29c by a specific antisense oligonucleotide significantly reduced albuminuria and kidney mesangial matrix accumulation in the db/db mice model in vivo. These findings identify miR-29c as a novel target in diabetic nephropathy and provide new insights into the role of miR-29c in a previously unrecognized signaling cascade involving Spry1 and Rho kinase activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,266
Etienne-Manneville, S., & Hall, A. (2002) · Nature · doi:10.1038/nature01148 · Cited by 4,201
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Fast and effective prediction of microRNA/target duplexes
REHMSMEIER, M., STEFFEN, P., HÖCHSMANN, M., & GIEGERICH, R. (2004) · RNA · doi:10.1261/rna.5248604 · Cited by 2,560
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., Watts, L., Booten, S. L., Graham, M., McKay, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.005 · Cited by 2,082
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805038105 · Cited by 1,844
Fabbri, M., Garzon, R., Cimmino, A., Liu, Z., Zanesi, N., Callegari, E., Liu, S., Alder, H., Costinean, S., Fernandez-Cymering, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707628104 · Cited by 1,673
Specificity of microRNA target selection in translational repression
Doench, J. G., & Sharp, P. A. (2004) · Genes & Development · doi:10.1101/gad.1184404 · Cited by 1,636
Lee, Y. S., & Dutta, A. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092222 · Cited by 1,505
The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution
Farh, K. K.-H., Grimson, A., Jan, C., Lewis, B. P., Johnston, W. K., Lim, L. P., Burge, C. B., & Bartel, D. P. (2005) · Science · doi:10.1126/science.1121158 · Cited by 1,484
miRNAs, Cancer, and Stem Cell Division
Croce, C. M., & Calin, G. A. (2005) · Cell · doi:10.1016/j.cell.2005.06.036 · Cited by 1,329
MicroRNA control of signal transduction
Inui, M., Martello, G., & Piccolo, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2868 · Cited by 1,272
Susztak, K., Raff, A. C., Schiffer, M., & Böttinger, E. P. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0894 · Cited by 1,096
Role of microRNAs in vascular diseases, inflammation, and angiogenesis
Urbich, C., Kuehbacher, A., & Dimmeler, S. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn156 · Cited by 880
Mundel, P., Reiser, J., Borja, A. Z. M., Pavenstädt, H., Davidson, G. R., Kriz, W., & Zeller, R. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3739 · Cited by 877
mir-29 regulates Mcl-1 protein expression and apoptosis
Mott, J. L., Kobayashi, S., Bronk, S. F., & Gores, G. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210436 · Cited by 834
Kato, M., Zhang, J., Wang, M., Lanting, L., Yuan, H., Rossi, J. J., & Natarajan, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611192104 · Cited by 699
MicroRNA detection by northern blotting using locked nucleic acid probes
Várallyay, É., Burgyán, J., & Havelda, Z. (2008) · Nature Protocols · doi:10.1038/nprot.2007.528 · Cited by 677
miR-29 miRNAs activate p53 by targeting p85α and CDC42
Park, S.-Y., Lee, J. H., Ha, M., Nam, J.-W., & Kim, V. N. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1533 · Cited by 606
NF-κB–YY1–miR-29 Regulatory Circuitry in Skeletal Myogenesis and Rhabdomyosarcoma
Wang, H., Garzon, R., Sun, H., Ladner, K. J., Singh, R., Dahlman, J., Cheng, A., Hall, B. M., Qualman, S. J., Chandler, D. S., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.006 · Cited by 593
Biological Functions of miR-29b Contribute to Positive Regulation of Osteoblast Differentiation
Li, Z., Hassan, M. Q., Jafferji, M., Aqeilan, R. I., Garzon, R., Croce, C. M., van Wijnen, A. J., Stein, J. L., Stein, G. S., & Lian, J. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809787200 · Cited by 589
Effects of Microrna-29 on Apoptosis, Tumorigenicity, and Prognosis of Hepatocellular Carcinoma
Xiong, Y., Fang, J.-H., Yun, J.-P., Yang, J., Zhang, Y., Jia, W.-H., & Zhuang, S.-M. (2010) · Hepatology · doi:10.1002/hep.23380 · Cited by 563
Rho Kinases in Cardiovascular Physiology and Pathophysiology
Loirand, G., Guérin, P., & Pacaud, P. (2006) · Circulation Research · doi:10.1161/01.res.0000201960.04223.3c · Cited by 547
A New Method for Large Scale Isolation of Kidney Glomeruli from Mice
Takemoto, M., Asker, N., Gerhardt, H., Lundkvist, A., Johansson, B. R., Saito, Y., & Betsholtz, C. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64239-3 · Cited by 516
PPM1A Functions as a Smad Phosphatase to Terminate TGFβ Signaling
Lin, X., Duan, X., Liang, Y.-Y., Su, Y., Wrighton, K. H., Long, J., Hu, M., Davis, C. M., Wang, J., Brunicardi, F. C., et al. (2006) · Cell · doi:10.1016/j.cell.2006.03.044 · Cited by 485
Self-citationMolecular mechanisms of diabetic renal hypertrophy
Wolf, G., & Ziyadeh, F. N. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00590.x · Cited by 472
MicroRNA 29b functions in acute myeloid leukemia
Garzon, R., Heaphy, C. E. A., Havelange, V., Fabbri, M., Volinia, S., Tsao, T., Zanesi, N., Kornblau, S. M., Marcucci, G., Calin, G. A., et al. (2009) · Blood · doi:10.1182/blood-2009-03-211938 · Cited by 459
Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling
Mason, J. M., Morrison, D. J., Albert Basson, M., & Licht, J. D. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.11.004 · Cited by 424
The Small GTPase Rho: Cellular Functions and Signal Transduction
Narumiya, S. (1996) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021401 · Cited by 409
Sengupta, S., den Boon, J. A., Chen, I.-H., Newton, M. A., Stanhope, S. A., Cheng, Y.-J., Chen, C.-J., Hildesheim, A., Sugden, B., & Ahlquist, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801130105 · Cited by 398
Wang, Q., Wang, Y., Minto, A. W., Wang, J., Shi, Q., Li, X., & Quigg, R. J. (2008) · The FASEB Journal · doi:10.1096/fj.08-112326 · Cited by 397
Self-citationIsermann, B., Vinnikov, I. A., Madhusudhan, T., Herzog, S., Kashif, M., Blautzik, J., Corat, M. A. F., Zeier, M., Blessing, E., Oh, J., et al. (2007) · Nature Medicine · doi:10.1038/nm1667 · Cited by 385
Mukhopadhyay, P., Rajesh, M., Haskó, G., Hawkins, B. J., Madesh, M., & Pacher, P. (2007) · Nature Protocols · doi:10.1038/nprot.2007.327 · Cited by 373
Modulation of signalling by Sprouty: a developing story
Kim, H. J., & Bar-Sagi, D. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1400 · Cited by 372
Sprouty1 Is a Critical Regulator of GDNF/RET-Mediated Kidney Induction
Basson, M. A., Akbulut, S., Watson-Johnson, J., Simon, R., Carroll, T. J., Shakya, R., Gross, I., Martin, G. R., Lufkin, T., McMahon, A. P., et al. (2005) · Developmental Cell · doi:10.1016/j.devcel.2004.12.004 · Cited by 362
Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element
Donello, J. E., Loeb, J. E., & Hope, T. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.5085-5092.1998 · Cited by 350
Zhao, J.-J., Lin, J., Lwin, T., Yang, H., Guo, J., Kong, W., Dessureault, S., Moscinski, L. C., Rezania, D., Dalton, W. S., et al. (2010) · Blood · doi:10.1182/blood-2009-09-243147 · Cited by 335
microRNAs: Master Regulators as Potential Therapeutics in Cancer
Garofalo, M., & Croce, C. M. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100517 · Cited by 291
Impagnatiello, M.-A., Weitzer, S., Gannon, G., Compagni, A., Cotten, M., & Christofori, G. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.5.1087 · Cited by 280
Long, J., Wang, Y., Wang, W., Chang, B. H. J., & Danesh, F. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.136168 · Cited by 267
Self-citationInhibition of microRNA with antisense oligonucleotides
Esau, C. C. (2008) · Methods · doi:10.1016/j.ymeth.2007.11.001 · Cited by 257
Mammalian Sprouty Proteins Inhibit Cell Growth and Differentiation by Preventing Ras Activation
Gross, I., Bassit, B., Benezra, M., & Licht, J. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108234200 · Cited by 251
Danesh, F. R., Sadeghi, M. M., Amro, N., Philips, C., Zeng, L., Lin, S., Sahai, A., & Kanwar, Y. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122228799 · Cited by 233
Self-citationWnt/Planar cell polarity signaling: A new paradigm for cancer therapy
Wang, Y. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0282 · Cited by 216
Self-citationKolavennu, V., Zeng, L., Peng, H., Wang, Y., & Danesh, F. R. (2008) · Diabetes · doi:10.2337/db07-1241 · Cited by 201
Self-citationPotent inhibition of microRNA in vivo without degradation
Davis, S., Propp, S., Freier, S. M., Jones, L. E., Serra, M. J., Kinberger, G., Bhat, B., Swayze, E. E., Bennett, C. F., & Esau, C. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn904 · Cited by 200
RhoA/Rho-Kinase Contribute to the Pathogenesis of Diabetic Renal Disease
Peng, F., Wu, D., Gao, B., Ingram, A. J., Zhang, B., Chorneyko, K., McKenzie, R., & Krepinsky, J. C. (2008) · Diabetes · doi:10.2337/db07-1149 · Cited by 184
Basson, M. A., Watson-Johnson, J., Shakya, R., Akbulut, S., Hyink, D. P., Costantini, F. D., Wilson, P. D., Mason, I. J., & Licht, J. D. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.08.051 · Cited by 154
Gojo, A., Utsunomiya, K., Taniguchi, K., Yokota, T., Ishizawa, S., Kanazawa, Y., Kurata, H., & Tajima, N. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.04.011 · Cited by 148
Re, D. P. D., Miyamoto, S., & Brown, J. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m604298200 · Cited by 145
Langley, R. R., Ramirez, K. M., Tsan, R. Z., Arsdall, M. R. V., Nilsson, M. B., & Fidler, I. J. (2003) · PubMed · Cited by 144
Fibronectin Matrix Assembly Requires Distinct Contributions from Rho Kinases I and -II
Yoneda, A., Ushakov, D., Multhaupt, H. A. B., & Couchman, J. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-08-0684 · Cited by 137
Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT
Long, J., Matsuura, I., He, D., Wang, G., Shuai, K., & Liu, F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1733973100 · Cited by 107
Self-citationKikuchi, Y., Yamada, M., Imakiire, T., Kushiyama, T., Higashi, K., Hyodo, N., Yamamoto, K., Oda, T., Suzuki, S., & Miura, S. (2007) · Journal of Endocrinology · doi:10.1677/joe-06-0045 · Cited by 106
Hyperglycemia and mechanical stress: Targeting the renal podocyte
Lewko, B., & Stępiński, J. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21856 · Cited by 105
Horwich, M. D., & Zamore, P. D. (2008) · Nature Protocols · doi:10.1038/nprot.2008.145 · Cited by 105
Miyoshi, K., Wakioka, T., Nishinakamura, H., Kamio, M., Yang, L., Inoue, M., Hasegawa, M., Yonemitsu, Y., Komiya, S., & Yoshimura, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207759 · Cited by 94
Searching for MiR-acles in Cardiac Fibrosis
van Rooij, E., & Olson, E. N. (2009) · Circulation Research · doi:10.1161/circresaha.108.192492 · Cited by 84
Groß, I., Morrison, D. J., Hyink, D. P., Georgas, K. M., English, M. A., Mericskay, M., Hosono, S., Sassoon, D. A., Wilson, P. D., Little, M. H., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306425200 · Cited by 82
Zeng, L., Xu, H., Chew, T., Eng, E., Sadeghi, M. M., Adler, S., Kanwar, Y. S., & Danesh, F. R. (2005) · The FASEB Journal · doi:10.1096/fj.05-4240fje · Cited by 68
Self-citationA system for Cre-regulated RNA interference in vivo
Stern, P., Astrof, S., Erkeland, S. J., Schustak, J., Sharp, P. A., & Hynes, R. O. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806907105 · Cited by 64
Xenopus Paraxial Protocadherin regulates morphogenesis by antagonizing Sprouty
Wang, Y., Janicki, P., Köster, I., Berger, C. D., Wenzl, C., Großhans, J., & Steinbeißer, H. (2008) · Genes & Development · doi:10.1101/gad.452908 · Cited by 58
Self-citationMicroRNAs in Cardiovascular Diseases: Biology and Potential Clinical Applications
Kartha, R. V., & Subramanian, S. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9172-z · Cited by 43
Sprouty1, a new target of the angiostatic agent 16K prolactin, negatively regulates angiogenesis
Sabatel, C., Cornet, A. M., Tabruyn, S. P., Malvaux, L., Castermans, K., MARTIAL, J. A., & Struman, I. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-231 · Cited by 41
Interactions of protein phosphatase type 1, with a focus on myosin phosphatase.
Hartshorne, D. J., & Hirano, K. (1999) · PubMed · Cited by 39
Interactions of protein phosphatase type 1, with a focus on myosin phosphatase
Hartshorne, D. J., & Hirano, K. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006917032557 · Cited by 31
VEGF gene expression is regulated post‐transcriptionally in macrophages
Du, M., Roy, K., Zhong, L., Shen, Z., Meyers, H. E., & Nichols, R. C. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05106.x · Cited by 29
Cited by
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rupaimoole, R., & Slack, F. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.246 · Cited by 4,741
Epigenetics and epigenomics in diabetic kidney disease and metabolic memory
Kato, M., & Natarajan, R. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0135-6 · Cited by 600
Inhibition of microRNA function by antimiR oligonucleotides
Stenvang, J., Petri, A., Lindow, M., Obad, S., & Kauppinen, S. (2012) · Silence · doi:10.1186/1758-907x-3-1 · Cited by 560
The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury
Kriegel, A. J., Liu, Y., Fang, Y., Ding, X., & Liang, M. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00141.2011 · Cited by 533
Suppression of microRNA-29 Expression by TGF-β1 Promotes Collagen Expression and Renal Fibrosis
Wang, B., Komers, R., Carew, R., Winbanks, C. E., Xu, B., Herman-Edelstein, M., Koh, P., Thomas, M., Jandeleit-Dahm, K., Gregorevic, P., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011010055 · Cited by 498
Metadata
- Authors
- Long, J., Wang, Y., Wang, W., Chang, B. H. J., & Danesh, F. R.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2011-04
- Volume
- 286
- Issue
- 13
- Pages
- 11837-11848
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2063404839
- Cited by
- 266
- References
- 71
- FWCI
- 18.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.